Clinical trials
Children clinical trials
Below are recruiting children clinical trials, each written for real people, not researchers. We’re tracking 2,992 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05839379Recruiting
Targeted therapy study for children and young adults with brain tumors
This trial studies a targeted medicine approach for high-grade glioma (a fast-growing brain tumor) and some diffuse midline tumors, including DIPG. It may help by matching treatment to tumor biology using tumor testing done before or around starting standard therapy.
Aurora, ColoradoAges 1–39 - NCT05842902Recruiting
Mobile app program to build resilience for young cancer patients
This trial tests a phone-based (mobile) resilience program for teens and young adults who were recently diagnosed with cancer. It aims to help you cope with cancer using interactive activities, interviews, and short surveys.
Seattle, WashingtonAges 12–25 - NCT05767047RecruitingPhase 3
Apremilast study for children with mouth ulcers from Behçet’s
This trial studies whether apremilast can help reduce mouth ulcers in children who have Behçet’s disease or juvenile psoriatic arthritis. You may be considered if your child finished a main study and is under 18, and can safely continue treatment.
ThessalonikiAges 5–18 - NCT05810636Enrolling by invitation
Activity tracking in children with ADHD
This study uses a smartwatch and smartphone to track the activity of children with and without ADHD. The goal is to understand how hyperactivity differs between groups.
TaipeiAges 6–18 - NCT05810181Recruiting
Interviews to improve choices about gene therapy for rare diseases
This study uses one-on-one interviews to learn what families and clinicians need to make decisions about gene therapy for rare diseases. The goal is to create or improve decision tools that make gene therapy information easier to understand and act on.
Memphis, TennesseeAges 8 years+ - NCT05783375Recruiting
Rheumatic heart prevention program for Ugandan communities
This study helps deliver prevention care for rheumatic heart disease in specific districts of northern Uganda. If you live there (or provide care in the selected clinics), the program may offer extra support to help stop heart damage before it starts.
Kampala, UgandaAges 5 years+ - NCT05809115Recruiting
Caregiver-child bonding support for hospitalized young children
This study looks at how a caregiver and their young child bond during a hospital stay, and whether extra support can help. It may help families feel more connected and supported while their child is in the hospital.
Houston, TexasAges 18 years+ - NCT05781295Recruiting
Taurolidine vs saline lock for kids’ central line
This trial studies whether a medicine lock called taurolidine is safer or works better than a standard saline (salt water) lock for pediatric cancer patients with central venous lines. It’s meant to help prevent central-line infections.
ParisAges Up to 21 years - NCT05803343Recruiting
Testing added benefits of including dogs for autism emotion control
This study tests whether adding dogs to therapy or activities helps children with autism better manage strong emotions and reactions. It may help families who are concerned about emotion outbursts or difficulty regulating feelings.
Cincinnati, OhioAges 8–15 - NCT05796440Enrolling by invitationPhase 2
Long-term safety study of LUM-201 in children with growth hormone deficiency
This trial checks the long-term safety of LUM-201 in children who have idiopathic growth hormone deficiency and already completed an earlier LUM-201 study. If you previously took LUM-201 and are allowed to continue, the study may help your care team monitor ongoing effects over time.
Iowa City, IowaAges 5–14 - NCT05766839RecruitingPhase 2
Potassium-lowering treatment for children under 12
This study tests a medicine called patiromer, which helps lower high potassium levels in the blood. It is for children under 12 who have high potassium that needs treatment for at least a month.
Aurora, ColoradoAges birth–11 years - NCT05753930RecruitingPhase 2
New medicine to help highly sensitised children receive kidney transplants
This trial tests a new medicine called imlifidase that quickly removes harmful antibodies from the blood. It is given to children before a kidney transplant to make the donated kidney more likely to be accepted, especially when standard desensitisation methods have failed.
HelsinkiAges 1–17 - NCT05748171RecruitingPhase 2
Testing inotuzumab for children with early ALL relapse
This Phase 2 study tests inotuzumab ozogamicin (InO), a cancer medicine, in children aged 1 to under 18 with a first relapse of ALL. It aims to find out how well and safely the medicine works when the leukemia comes back early.
ViennaAges 1–17 - NCT05777512Recruiting
Comparing feeding tube placement to improve breathing in preterm infants
This study tests whether placing a feeding tube past the stomach (postpyloric) can help very premature babies with ongoing lung problems breathe better. Infants born before 32 weeks who still need breathing support may join.
Boston, MassachusettsAges birth–1 year - NCT05762796Recruiting
Brain scan and stimulation study for kids with mild concussion
This study tests whether a brain “stimulation” approach, paired with brain imaging (MRI), can help children who still have symptoms after a mild concussion. There is also a comparison group of children without concussion history.
Buffalo, New YorkAges 10–15 - NCT05750095Recruiting
Parenting support program for children with autism
This trial tests parenting programs designed for parents of young children with autism (ages 2–6). It may help you learn practical ways to support your child and your family day to day.
BergenAges 2–6 - NCT05761899RecruitingPhase 1/Phase 2
Gene-corrected lung immune cells for a rare lung disease
This early-phase study tests a treatment that uses gene-corrected immune cells to treat hPAP, a rare lung condition. The goal is to check safety and see whether the treatment improves breathing and lung function.
Cincinnati, OhioAges 18 years+ - NCT05754073RecruitingPhase 2
Oxytocin to improve bone health in children with autism
This Phase 2 study tests whether oxytocin can help improve bone health in children and teens with autism spectrum disorder. It also checks safety by monitoring symptoms and doing blood tests and imaging.
Boston, MassachusettsAges 6–18 - NCT05750498Recruiting
Study to improve outcomes in autoimmune liver disease
This trial tests approaches to improve health outcomes for people with autoimmune liver diseases. It includes specific autoimmune conditions affecting the liver and bile ducts, and it may help your care team learn what works best for these illnesses.
Palo Alto, CaliforniaAges Any age - NCT05775367Recruiting
Cochlear implants for young children with one-sided deafness
This study checks whether cochlear implants help young children (ages about 7 months to under 3 years) who have very severe hearing loss in one ear. It also compares them with similar children who do not get implants, to understand what outcomes to expect.
Durham, North CarolinaAges 7 months–5.9 years - NCT05754632Recruiting
Blood flow restriction exercises after ACL surgery in teens
This trial tests whether a special type of exercise that uses a cuff (blood flow restriction training, or BFRT) can help teens recover after ACL reconstruction. It’s designed to see if adding BFRT to standard rehab improves strength and return to sport.
Farmington, ConnecticutAges 12–18 - NCT05770622RecruitingPhase 4
Vancocin dosing check in young infants with infections
This trial studies a better way to monitor and adjust vancomycin (an antibiotic) dosing in very young infants. It may help your baby get the right dose while reducing the risk of under- or over-dosing.
Melbourne, VictoriaAges birth–3 months - NCT05770661Recruiting
Study of eye growth length in children in China
This study looks at how a child’s eye “length” changes as they grow. It may help researchers understand patterns in eye development and who may be at higher risk for future vision problems.
Shanghai, Shanghai MunicipalityAges 3–18 - NCT05772962Recruiting
Dental record study for children at risk
This study collects children’s dental records to learn about oral health in children who are considered at risk. Your participation could help researchers understand what dental problems happen more often and why.
Bergen, VestlandAges birth–18 years
Hear when a new Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for children?
- Yes. Clin2 currently lists 2,992 recruiting children studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a children trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a children trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.